


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-0.24%
-2.07%
+1.80%
+1.80%
+0.04%
TMDX
TransMedics Group In
$123.00
Strengths

Earnings are forecast to grow

Upgraded on attractively valued
TMDX Price Performance
$140.1 (-12.21%)
$113.93 (+7.96%)
$114.5 (+7.42%)
$58.02 (+112.00%)
TMDX has Fair risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

TMDX overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Reported a strong earnings

Revenue increase YoY

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
TMDX Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
TMDX Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels
What is TMDX current stock price?
What are TMDX stock strengths?
What is TMDX Risk Level?
What is TMDX market cap and volume?
What is TMDX current Stock IQ?
Should I buy TMDX stock right now?
Is TMDX a Strong Buy right now?
What does a 'Strong Buy' rating mean for TMDX?
What does a 'Strong Sell' rating mean for TMDX?
What factors influence TMDX's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-0.24%
-2.07%
+1.80%
+1.80%
+0.04%
TMDX
TransMedics Group In
Current Price
$123.00
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

TMDX Price Performance
$140.1 (-12.21%)
$113.93 (+7.96%)
$114.5 (+7.42%)
$58.02 (+112.00%)
TMDX Analysts Opinion
TMDX Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Reported a strong earnings

Revenue increase YoY

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
TMDX Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
TMDX Street Sentiment is extremely bullish and have positive views on the near-term outlook
TMDX has Fair risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Average key support and resistance price levels
TMDX Stock IQ
TMDX Latest Analysis
TransMedics to Participate in the 44th Annual J.P. Morgan Healthcare Conference. ANDOVER Mass. Dec. 30 2025 /PRNewswire/ -- TransMedics Group Inc. (TransMedics) (Nasdaq: TMDX) a medical technology company that is transforming organ transplant therapy for patients with end-stage lung heart and liver failure today announced that members of the management team...
Tue Dec 30, 2025
Heres Why TransMedics (TMDX) is a Strong Growth Stock. Wondering how to pick strong market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Fri Dec 26, 2025
TransMedics Group: I Estimate A Large Upside By The End Of 2028.
Wed Dec 24, 2025
Heres How Much $1000 Invested In TransMedics Group 5 Years Ago Would Be Worth Today. TransMedics Group (NASDAQ:) has outperformed the market over the past 5 years by 33.44% on an annualized basis producing an average annual return of 46.51%. Currently TransMedics Group has a market capitalization of $4.38 billion.
Tue Dec 23, 2025
Canaccord Genuity Maintains TransMedics Group (TMDX) Buy Recommendation. Fintel reports that on December 17 2025 Canaccord Genuity maintained coverage of TransMedics Group (NasdaqGM:TMDX) with a Buy recommendation. Analyst Price Forecast Suggests 20.89% Upside
Thu Dec 18, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
TMDX Stock trends
TMDX Stock performance
TMDX Stock analysis
TMDX investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.